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Currently, nonanimal methods of skin sensitization testing for various chemicals, biodegradable polymers, and biomaterials are
being developed in the hope of eliminating the use of animals. The human cell line activation test (h-CLAT) is a skin sensitization
assessment that mimics the functions of dendritic cells (DCs). DCs are specialized antigen-presenting cells, and they interact with
T cells and B cells to initiate immune responses. Phenotypic changes in DCs, such as the production of CD86 and CD54 and
internalization of MHC class II molecules, have become focal points of the skin sensitization test. In this study, we used h-CLAT to
assess the eﬀects of biodegradable polymers. The results showed that several biodegradable polymers increased the expression of
CD54, and the relative skin sensitizing abilities of biodegradable polymers were PLLG (75:25) < PLLC (40:60) < PLGA (50:50)
< PCG (50:50). These results may contribute to the creation of new guidelines for the use of biodegradable polymers in scaﬀolds
or allergenic hazards.
1.Introduction
Until recently, studies of skin sensitization have used the
guinea pig maximization test (GPMT) [1–3]. Currently, the
local lymph node assay (LLNA) [4, 5] is often used as an
alternative to GPMT. The advantages of LLNA are the ability
to make dose-dependent evaluations, a decrease in animal
usage, shorter experimental time periods, and lower costs
[6,7].Inaddition,amovementtoprohibittheuseofanimals
for safety testing of new materials is spreading throughout
the world [8]. Recently, Ashikage et al. (2006) [9], Sakaguchi
et al. (2006) [10] and several laboratories have reported the
use of a new alternative to animal experiments, the human
cell line activation test (h-CLAT) [11, 12].
Dendritic cells (DCs) are in contact with the skin and
inner lining of the nose, lungs, stomach, and intestines
[13]. They can also be found in an immature state in
the blood. Antigens from viruses and microbes not only
induce an adaptive immune response in DCs but also
induce innate immunity to activate the immune system
[14–16]. When skin sensitization develops, DCs immigrate
to the secondary lymphoid organs to present na¨ ıve T
cells [17]. Then, immature DCs mature and intercellular
adhesion molecules, costimulatory molecules, and major
histocompatibility complex II (MHC II) antigens (CD54,
CD86, HLA-DR antigens) [18–21]. The immune reaction
of DCs remains weak without costimulatory molecules.
Therefore,skinsensitization in invitroexperiments is judged
by expressions of CD54 and CD86.
THP-1 cells, a human monocyte cell line, are used in
place of DCs in h-CLAT. We can evaluate phenotypical
alterations on these THP-1 cells. In the present studies, we
assessed skin sensitization to biodegradable polymers by in
vitro measures.
2.MaterialsandMethods
2.1. Cell Cultivation. THP-1 cells purchased from American
Type Culture Collection (Manassas, Va, USA) were cultured
with RPMI Medium 1640 (GIBCO, Grand Island, NY, USA)
supplemented with 10% fetal bovine serum (FBS, Intergen,
Purchase, NY, USA), 0.05mM 2-mercaptoethanol (GIBCO),2 International Journal of Biomaterials
Table 1: Condition and composition of biodegradable polymers.
Sample Biodegradable polymer Composition Mn∗ Catalyst
P1 Poly(L-lactide-glycolide copolymer)(PLLG) 75:25 3540 Without
P2 Poly(L-lactide-glycolide copolymer)(PLLG) 75:25 3580 SnOct2
P3 Poly(X,L-lactide-glycolide copolymer)(PLGA) 50:50 3550 Without
P4 Poly(L-lactide)(PLLA) 100 3390 Without
P5 Poly(L-lactide-caprolactone copolymer)(PLLC) 40:60 3110 Without
P6 Poly(caprolactone glycolide copolymer)(PCG) 50:50 3000 Without
∗number average molecular weight (Mn).
and1%streptomycin(GIBCO).Thecellsusedintestingwere
between 2 weeks to 2 months old.
2.2. Biodegradable Polymers and Their Treatment.
B i o d e g r a d a b l ep o l y m e r sP 1t oP 6( Table 1) were obtained
from Taki Chemical Co., Ltd. (Hyogo, Japan). We made
6 initial stock solutions by dissolving the biodegradable
polymers in dimethyl sulfoxide (DMSO, Sigma, Ayrshire,
UK). The biodegradable polymers P1, P2, P3, P4,
P5, and P6 were dissolved separately in DMSO. 2,4-
Dinitrochlorobenzene (DNCB, Sigma-Aldrich, St. Louis,
Mo, USA) was also dissolved in DMSO and used as a positive
control for the skin sensitization test. We made 6 substock
solutions of each polymer using two-times dilution series.
These sub-stock solutions were diluted 20 times with RPMI
medium 1640. Finally, the working solutions were added to
the cells at 100 times dilution.
2.3. Analysis by Flow Cytometry. Cells were seeded on 96-
well plate (Corning, Corning, NY, USA) at a density of
1.6 × 105 (cells/160μL/well) with the working solutions
a n dc u l t i v a t e di naC O 2 incubator for 24h. The cultivated
cells were moved to V-shaped culture plates (BMbio, Tokyo,
Japan), and then the cells were collected by centrifuging at
700×g for 3min. The cells were washed 3 times using FACS
buﬀer (PBS+0.1% BSA). They were blocked with 200μLo f
0.01% Globulins Cohn fraction II and III (Sigma-Aldrich,
St. Louis, MO, USA) for 15min on ice. The supernatants
were removed from the plate after centrifuging. Fluorescein
isothiocyanate (FITC)-conjugated mouse antihuman CD86
antibody(CD86,BDPharmingen,SanJose,CA,USA),mon-
oclonal mouse anti-human CD54, ICAM-1/FITC antibody,
(CD54, Dako, Denmark), or mouse IgG1/FITC antibody
(IgG, Dako) was added to the plates, and the plates were
shaded from the light for 30min. The plates were washed 3
t i m e sw i t hF A C Sb u ﬀer. Finally, the cells were resuspended
in 400μLF A C Sb u ﬀe ra n ds u b j e c t e dt oﬂ o wc y t o m e t r yo n
a BD FACSCalibur cell sorter (Becton Dickinson Co., Ltd.,
Franklin Lakes, NJ, USA) to analyze the surface of the cells
for CD markers.
2.4. Propidium Iodide Assay of Cell Viability. During ﬂow
cytometry analysis, propidium iodide (PI, 0.625μg/mL) was
added to the suspended cells to measure the number of
living cells. Each test was done in triplicate, and 10,000 living
cells were counted each time by the BD FACSCalibur ﬂow
cytometer.
2.5. Relative Fluorescence Intensity. We separated the living
cells from the PI-dyed dead cells using the Flowjo computer
program. We evaluated the skin sensitization caused by
the biodegradable polymers by measuring the ﬂuorescence
intensity of CD86, CD54, and IgG. At less than 50% cell
viability, there is a possibility of cell wall damage and
irregular binding of antibodies. Therefore, we measured cell
viability by calculating the relative ﬂuorescence intensity
(RFI) as shown below by the expression levels of CD86 and
CD54.
RFI(%) =
MFI of cells with polymer −MFI of isotype control cells with polymer
MFI of vehicle control cells −MFI of vehicle isotype control cells
× 100 (1)
∗MFI: (geometric) mean of ﬂuorescence intensity.
3. Results
3.1. Cell Viability by PI Assay. DNCB, a positive control,
was used to test cell viability and expression levels of the
CD markers on THP-1 cells. DNCB at 5.2μg/mL produced
high RFI expression levels, while the changes in cell viability
were miniscule. At the same time, we tested the eﬀect of
the DMSO solvent on cell viability over time (Figure 1). The
cell viabilities did not change during the 24-hour incubation
with DNCB and DMSO. These results show that a 24-
hours incubation and 5.2μg/mL DNCB were an appropriate
incubation time and concentration for the skin sensitization
test.
Next we tested the eﬀe c t so fb i o d e g r a d a b l ep o l y m e r so n
the viabilities of THP-1 cells. The cells were incubated for 24
hourswithvariousconcentrationsofthebiodegradablepoly-
mers and subjected to PI assay (Figure 2). The results showInternational Journal of Biomaterials 3
0
20
40
60
80
100
120
C
e
l
l
v
i
a
b
i
l
i
t
y
(
%
)
1h 6h 12h 24h 48h
(a)
0
20
40
60
80
100
120
C
e
l
l
v
i
a
b
i
l
i
t
y
(
%
)
1h 6h 12h 24h 48h
(b)
0
20
40
60
80
100
120
C
e
l
l
v
i
a
b
i
l
i
t
y
(
%
)
1h 6h 12h 24h 48h
(c)
0
100
200
300
400
500
600
R
F
I
(
%
)
CD86
CD54
1h 6h 12h 24h 48h
(d)
Figure 1: Comparison between cell viabilities of positive control, solvent, and medium only. All cell viabilities were measured by time
progression. (a) Cell viability in RPMI medium 1640, (b) cell viability in DMSO (2μL/mL), (c) cell viability in DNCB (5.2μg/mL), and (d)
CD54 and CD86 expression levels over time with DNCB (5.2μg/mL).
that cell viabilities diﬀered depending on the biodegradable
polymer. However, the tendencies of decreasing cell viabili-
ties were proportional to the concentrations of the polymers.
Sample P6 was not tested because it did not dissolve at
2mg/mL.
3.2. Expression of CD54 and CD86 Markers (Alternative RFI).
After 24-hour incubation, variations of the RFI as an index
of skin sensitization were determined by measuring the
ﬂuorescence intensity of CD86 and CD54 immune markers.
The CD54 RFI increased dose dependently with increased
concentration of all polymers (Figure 3). In contrast, the
CD86 RFI decreased in all of the polymer solutions. These
results showed that as the concentrations of degradable poly-
mers were augmented, only the CD54 marker was expressed.
P1, P3, P5, and P6 produced high skin sensitization as shown
bytheRFIreaching200.Inparticular,P6showedanRFIover
200 at 250μg/mL.
3.3. Estimated Concentration of CD54 in Biodegradable Poly-
mers. From the RFI experiments (Figure 3), we know that
someofthebiodegradablepolymerscauseexpressionofonly
CD54 costimulatory molecules on the dendritic cells. Based
on previous studies, the eﬀective concentrations (EC) 200
(CD54) and EC150 (CD86) became the standard for judging
skin sensitization in cases of CD54. P1, P3, P5, and P6 were
estimated to cause skin sensitization by this method, at the
concentrations of polymers shown in Table 2.
4. Discussion
Since the role of DCs in skin sensitization has been known,
researchusing human peripheral blood has expanded, butits
use has limits due to the limited number of DCs in the blood
[22, 23]. The expression levels of the markers CD54 and
CD86 have been shown to be closely related to how sensitive
skinis[24,25].PreviousstudieshavesetRFIvaluecriteriafor4 International Journal of Biomaterials
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Figure 2: Eﬀects of biodegradable polymers on cell viability by concentration. THP-1 cells were incubated with dissolved biodegradable
polymers for 24 hours. Using ﬂow cytometry with PI (0.625μg/mL), only living cells were counted in total cells. (a) P1, (b) P2, (c) P3, (d)
P4, (e) P5, and (f) P6, N.T.: not tested.
Table 2: Eﬀects of EC 200 on biodegradable polymers.
Sample
Low
FRI
Low
conc.
High
RFI
High
conc. EC (mg/mL)
abcd
P1 174.00 1.00 265.00 2.00 1.29
P3 178.00 0.62 250.00 1.25 0.81
P5 104.00 0.50 212.00 1.00 0.94
P6 108.00 0.13 236.00 0.25 0.21
Formula: EC200 = (d −b)/(c −a) ×(200 −a) +b.
CD86 (≥150%) and CD54 (≥200%) [26, 27]. In this study,
weusedh-CLATastheinvitroskinsensitizationmethodand
investigated whether biodegradable polymers sensitize skin
by using these markers in vitro. The expression levels of these
markers on cells were ﬁrst counted by geometric means of
ﬂow cytometry, and then the RFI values were calculated by
the RFI formula. Polymers that stimulated CD86 at 150%
or more and CD54 at 200% or more were judged to be
sensitizers as in previous studies.
Initially,wetestedtheeﬀectsofDNCBandDMSOoncell
viability over time. When the cell viability of the medium
concentration group was assumed to be 100%, the cell
viability oftheDMSOgroupshowed onlyminusculechange.
After48hours,thecellviabilityofboththeDMSOgroupand
themediumconcentrationgrouphaddecreasedonlyslightly.
The results showed that the cell viability was not changed
by the solvent DMSO (Figure 1). Further, the addition of
5.2μg/mL of DNCB to the cells did not result in a large
change in cell viability up to 24 hours. At 48 hours, however,
the cell viability had decreased to less than 60%. Therefore,
using DNCB as the positive control for skin sensitization was
most appropriate when the marker was measured after 24
hours.
We cultured all samples with biodegradable polymers
and measured the cell viability and expression levels of
CD54 and CD86 at 24 hours. Each polymer exerted a
diﬀerent eﬀect on cell viability (Figure 2). We found that
polymer P4 sharply decreased the cell viability as the dosage
was increased; therefore, it was possibly the most toxic
biodegradable polymer. The polymers P1 and P5 at the
highest concentration showed cell viabilities of 70% or more.
Therefore, their eﬀect on cell viability is considered weak.
The polymers increased the expression of the CD54
marker but did not increase the expression of the CD86
marker (Figure 3). The P1, P3, P5, and P6 polymers stim-
ulated high expression levels of the CD54 marker. P1 and
P5 stimulated high expression levels of the CD54 marker
while not aﬀecting cell viability. P4 produced the lowest
expressionoftheCD54markerandthelowestcellviabilityof
all the polymers. These results suggest that the biodegradable
polymers aﬀect only the CD54 marker and diﬀer in their
composition.
During the past several decades, biodegradable polymers
have been used in clinical medicine, and they have been
reported to have minimal to more substantial side eﬀects
[28,29].Generally,itisknownthattherearedelayedantigen-
antibodyreactionsduetopartialwear-outandinﬂammationInternational Journal of Biomaterials 5
0
100
200
300
Concentration (mg/mL)
R
F
I
(
%
)
Ctrl 0.125 0.25 0.5 1 2
(a)
R
F
I
(
%
)
0
100
200
300
Concentration (mg/mL)
Ctrl 0.125 0.25 0.5 1 2
(b)
R
F
I
(
%
)
0
200
400
600
Concentration (mg/mL)
Ctrl 0.16 0.31 0.62 1.25 2.5
(c)
R
F
I
(
%
)
0
100
200
300
Concentration (mg/mL)
Ctrl 0.125 0.25 0.5 1 2
CD54
CD86
(d)
Concentration (mg/mL)
Ctrl 0.125 0.25 0.5 1 2
R
F
I
(
%
)
0
100
200
300
CD54
CD86
(e)
1200
R
F
I
(
%
)
0
400
800
Concentration (mg/mL)
Ctrl 0.125 0.25 0.5 1 2
CD54
CD86
(f)
Figure 3: RFI results for each biodegradable polymers. Only living cells were selected by using PI dye. Next, we displayed living cells as FITC
histograms, and then we showed the power of the Geom mean. RFI (%) was calculated from Geom mean as described in test. (a) P1, (b) P2,
(c) P3, (d) P4, (e) P5, and (f) P6, N.T.: not tested.
duetolongusageofabiomedicalmaterial.Thisresearchmay
suggestthatthereisarelationshipbetweenCD54anddelayed
antigen-antibody reactions. It is thought to be necessary to
compare the results of the eﬀects of biodegradable polymers
on dendritic cells with those of local lymph node assays
(LLNA).
5. Conclusion
Until now, biodegradable polymers have been little studied
as causes of in vitro sensitization. We tested biodegradable
polymers by h-CLAT. We could not assess P4 because
even a low concentration of P4 caused cell death. Further,
skin sensitization was not increased by P2. Biodegradable
polymers that showed evidence of causing skin sensitization
expressed as only CD54 were PLLG (75:25) < PLLC (40:60)
< PLGA (50:50) < PCG (50:50). We determined that the
diﬀerent compositions of biodegradable polymers produced
clearly diﬀerent eﬀects on skin sensitization. In conclusion,
skin sensitization due to exposure to the biodegradable
polymers can be examined without animal experiments.
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